edited by Gotthard Schettler, Andreas J.R. Habenicht.
Berlin, Heidelberg
Springer Berlin Heidelberg
1994
(xxiii, 502 pages 75 illustrations)
Handbook of experimental pharmacology, 109.
Section A: Physiology and Pathophysiology of Lipid Metabolism --;1 An Introduction to the Biochemistry and Biology of Blood Lipids and Lipoproteins --;2 Lipoprotein Metabolism --;3 Lipoprotein Receptors --;4 Genetic Disorders of Lipoprotein Metabolism --;5 Interactions Between Lipoproteins and the Arterial Wall --;6 Lipoprotein Lipase and Hepatic Lipase --;7 Animal Models of Lipoprotein Metabolism --;Section B: Lipid Lowering Therapy --;8 Rationale to Treat --;9 The Dietary Therapy of Hyperlipidemia: Its Important Role in the Prevention of Coronary Heart Disease --;10 Lipid Apheresis --;Section C: Lipid Lowering Drugs --;11 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors --;12 Fibrates --;13 Nicotinic Acid and Derivatives --;14 Ion Exchange Resins --;15 Probucol --;16 Miscellaneous Lipid-Lowering Drugs.
This book is an update of the treatment of hyperlipidemia, necessary due to the identification in recent years of molecular mechanisms of atherogenesis. Emphasis is on the disease etiology of arteriosclerosis, the treatment of associated or causing diseases and treatment by dietary means or hypolipidemic drugs.
Human physiology.
Medicine.
Toxicology.
RC632
.
L54
E358
1994
edited by Gotthard Schettler, Andreas J.R. Habenicht.